About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse

NCT05732974•University Hospital, Toulouse

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Non-small Cell Lung Cancer Stage IIIA

Interventions

Resected non small cell lung cancer

Locations

1

France

Locations (1)

Julien MAZIERES

Toulouse, France

Key Dates

Start Date

March 30, 2023

Primary Completion Date

November 30, 2025

Completion Date

October 30, 2026

Last Updated

September 21, 2023

Related Studies

TERMINATEDPhase 3

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

NCT02974426

Non-small Cell Lung Cancer Stage IIIARadiotherapy

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

NCT02977169

Non-small Cell Lung Cancer Stage IIIARadiotherapy

Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection

NCT01926483

Non-small Cell Lung Cancer Stage IIIA

Contacts

Julien MAZIERES, MD, PhD

CONTACT

0567771837 mazieres.j@chu-toulouse.fr

Sponsors

Lead Sponsor

University Hospital, Toulouse

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 21, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions